Viewing Study NCT02016534


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2026-03-03 @ 12:44 AM
Study NCT ID: NCT02016534
Status: TERMINATED
Last Update Posted: 2017-07-02
First Post: 2013-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stomach Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MET Amplified Gastric / Gastroesophageal Junction / Esophageal Adenocarcinoma, or … View